Couling John D sold $408K of DLB

Couling John D (SVP, Entertainment) sold 7,667 shares of Dolby Laboratories, Inc. (DLB) at $53.20 ($0.41M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Couling John D
Published Jul 6, 2026, 9:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

Traders may monitor for patterns in insider activity, but a single 10b5-1 sale of ~$408K is typically not a standalone catalyst.

02

Market read

A routine 10b5-1 insider sale was filed; likely limited incremental information for trading decisions.

03

What to watch

The article provides only the sale details; it does not include any concurrent buys, option exercises, or broader insider activity trends that would better contextualize the signal.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-06 after-hours; reflects sale executed 2026-07-01.

Background

The disclosure is a SEC Form 4 insider transaction by Dolby Laboratories SVP, executed via an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby Laboratories SVP Couling John D sold 7,667 shares on 2026-07-01 under a pre-arranged 10b5-1 plan for ~$407.9K.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear read-through to the broader media/AV software or entertainment tech sector from a single 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with personal liquidity needs or reduced internal conviction, potentially pressuring sentiment if investors overreact.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider transaction; SVP sold shares under a 10b5-1 plan.

  • Couling John D

    SVP, Entertainment; executed an open-market sale of 7,667 shares on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.